Metis: Pivotal Open-Label Randomized Study Of Radiosurgery With Or Without Tumor Treating Fields (Ttfields) For 1-10 Brain Metastases From Non-Small Cell Lung Cancer (Nsclc).

Brief Description Of Study

The METIS trial is designed to investigate the efficacy of the NovoTTF-100M device in treating patients non-small cell lung cancer (NSCLC) with metastases to the brain. The eligible subjects must have 1 inoperable brain metastasis or 2-10 brain lesions and must be able to carry the NovoTTF-100M device. Subjects enrolled in the treatment arm of the study will wear the device for at least 18 hours a day, on average, and have study visits roughly every 2 months for 10-15 months. For additional information regarding this clinical trial visit

Additional Information About The Study

For more details please visit iConnect and/or email us at Image retrieved from

Clinical Study Identifier: 02831959

Contact research investigator to learn more about this study by filling out the form below.

To: Research Study Investigator
Subject: I am interested in participating in your Research Study
Dear Investigator,
I'm interested in learning more about and participating in your research study named: METIS: Pivotal open-label randomized study of radiosurgery with or without Tumor Treating Fields (TTFields) for 1-10 brain metastases from non-small cell lung cancer (NSCLC).
I am hoping to hear back from you and discuss details of the study

By clicking "Contact Research Team", your contact information will be sent directly to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.